Novartis Investigative Site — Honolulu, Hawaii

Novartis Investigative Site is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 26 clinical trials.

Therapeutic areas: Major Depressive Disorder, Relapsing Multiple Sclerosis, Chronic Obstructive Pulmonary Disease (COPD).

Sponsors: Novartis, Novartis Pharmaceuticals, Debiopharm International SA.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 26 clinical trials on record. Their work covers Major Depressive Disorder, Relapsing Multiple Sclerosis, Chronic Obstructive Pulmonary Disease (COPD).

Is Novartis Investigative Site accredited by Crixeo Health?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.